Literature DB >> 32749496

The Development of COVID-19 Vaccines: Safeguards Needed.

Nicole Lurie1, Joshua M Sharfstein2, Jesse L Goodman3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32749496     DOI: 10.1001/jama.2020.12461

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  'Why Should I Take the COVID-19 Vaccine after Recovering from the Disease?' A Mixed-methods Study of Correlates of COVID-19 Vaccine Acceptability among Health Workers in Northern Nigeria.

Authors:  Zubairu Iliyasu; Muhammad R Garba; Auwalu U Gajida; Taiwo G Amole; Amina A Umar; Hadiza M Abdullahi; Aminatu A Kwaku; Hamisu M Salihu; Muktar H Aliyu
Journal:  Pathog Glob Health       Date:  2021-12-22       Impact factor: 3.735

2.  "They have produced a vaccine, but we doubt if COVID-19 exists": correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria.

Authors:  Zubairu Iliyasu; Amina A Umar; Hadiza M Abdullahi; Aminatu A Kwaku; Taiwo G Amole; Fatimah I Tsiga-Ahmed; Rayyan M Garba; Hamisu M Salihu; Muktar H Aliyu
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

3.  Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.

Authors:  Nir Eyal; Tobias Gerhard; Brian L Strom
Journal:  Vaccine       Date:  2021-04-30       Impact factor: 3.641

4.  Sleep in post-COVID-19 recovery period and its impact on different domains of quality of life.

Authors:  Samir El Sayed; Sarah Gomaa; Doaa Shokry; Ahmed Kabil; Ahmed Eissa
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2021-12-14

5.  The role of good governance in the race for global vaccination during the COVID-19 pandemic.

Authors:  Moosa Tatar; Mohammad Reza Faraji; Jalal Montazeri Shoorekchali; José A Pagán; Fernando A Wilson
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

6.  COVID-19: Non-Invasive Ventilation in Hypoxemic Acute Respiratory Failure.

Authors:  Fariborz Rezaeitalab; Fariba Rezaeetalab; Farzaneh Akbari; Seyyed Mohammad Ata Sharifi Dalooei; Soheila Saberi; Saeedeh S Mirtouni
Journal:  Int J Prev Med       Date:  2022-01-18

7.  Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

Authors:  Hu-Dachuan Jiang; Li Zhang; Jing-Xin Li; Feng-Cai Zhu
Journal:  Engineering (Beijing)       Date:  2021-05-19       Impact factor: 7.553

8.  Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence.

Authors:  Xuerong Liu; Mengyin Zhu; Rong Zhang; Jingxuan Zhang; Chenyan Zhang; Peiwei Liu; Zhengzhi Feng; Zhiyi Chen
Journal:  Transl Psychiatry       Date:  2021-07-09       Impact factor: 6.222

9.  Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.

Authors:  Archana Asundi; Colin O'Leary; Nahid Bhadelia
Journal:  Cell Host Microbe       Date:  2021-07-14       Impact factor: 21.023

10.  Perspectives of dermatology specialists and residents on COVID-19 vaccines: A questionnaire-based survey.

Authors:  Efsun Tanacan; Ogulcan Ibis; Gulhan Aksoy Sarac; Mehmet Ali Can Emeksiz; Didem Dincer; Fatma Gulru Erdogan
Journal:  Int J Clin Pract       Date:  2021-08-04       Impact factor: 3.149

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.